Faculty

Institution

Unit

Venue

Anastasia Levitin

Keck Graduate Institute

Affiliations

School of Medicine

NoneAnastasia Levitin is currently serving as a School Of Medicine faculty at Keck Graduate Institute.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Anastasia Levitin

Keck Graduate Institute

You can click a keyword to filter the displayed items

infectious diseases infection control clinical microbiology microbiology public health pathogens microbial pathogenesis virology virus research antiviral research pharmacology pathogenic bacteria antimicrobial resistance antibiotics bacteria applied microbiology antimicrobial agents host response antimicrobial compounds antimicrobial chemotherapy antimicrobial susceptibility host-microbe interactions emerging infectious diseases antiviral drugs antiviral therapy veterinary medicine hospital infections pharmaceutics cell death molecular cell biology cancer cells cellular biochemistry pharmacotherapy natural product communication genome biology heredity viral persistence virus-host interactions viral diagnostics antimicrobial stewardship antibiotic adjuvant signaling pathways apoptosis molecular pathways cell regulation disease transmission antiparasitic agent drug targeting drug development virulence factors antibiotic resistance antibacterial agents genetic mechanisms host genetics gene evolution vector borne disease arbovirus antiviral drug development clinical infectious disease multiple toxins bacterial toxins bacterial infections anthrax toxin component protective antigen clinically approved drugs small molecule host-targeting therapy repurposed amodiaquine pathogenic agents microbial infections zika virus drug repurposing

Notable Scholarly Works

Notable Federal Grants

Collaborators

Drosophila Melanogaster Y Chromosome Genes Affect Male Sensitivity to Microbial Infections. Insects (2021)

genomicsgenome biologygenetic mechanismshost geneticsmicrobial pathogenesishereditygeneticsmicrobial infectionsreproductive biologymolecular geneticsinfectious diseasesinsect molecular biologygene evolutionmicrobiologyhost-microbe interactions

In Vivo Activity of Repurposed Amodiaquine as a Host-Targeting Therapy for the Treatment of Anthrax. ACS Infectious Diseases (2021)

Mikhail Martchenko ShilmanGloria BartoloSaleem AlamehJohnny W. PetersonWilliam S. LawrenceJennifer E. PeelSatheesh K. SivasubramaniDavid W. C. BeasleyChristopher K. CoteSamandra T. DemonsStephanie A. HalasahorisLynda L. MillerChristopher P. KlimkoJennifer L. ShoeDavid P. FettererRyan McCombChi-Lee C. HoKenneth A. BradleyStella HartmannLuisa W. ChengMarina ChugunovaChiu-Yen KaoJennifer K. TranAram DerbedrossianLeeor ZilbermintzEmiene Amali-AdekwuAnastasia LevitinJoel West

medicinedisease transmissionpharmacologyhost-targeting therapyinfection controlpharmacotherapyrepurposed amodiaquinedrug discoveryantiparasitic agentdrug targetinginfectious diseasesdrug developmentemerging infectious diseases

Anthrax Toxin Component, Protective Antigen, Protects Insects From Bacterial Infections. PLoS Pathogens (2020)

Saleem AlamehGloria BartoloSummer O’BrienElizabeth A. HendersonLeandra O. GonzalezStella HartmannChristopher P. KlimkoJennifer L. ShoeChristopher K. CoteLaurence K. GrillAnastasia LevitinMikhail Martchenko Shilman

public healthpathogensbacterial infectionsanthrax toxin componentprotective antigen

Identification of Bithionol, Dichlorophen, and Miconazole as Antibacterial Agents Against Acinetobacter Calcoaceticus. ACS Omega (2020)

antimicrobial agentsantimicrobial resistanceantibiotic resistancebioorganic chemistryantimicrobial compoundsclinical microbiologyapplied microbiologyantimicrobial susceptibilitydrug resistanceantibioticsantibacterial agentsnatural product communicationinfectious diseasesbacteriabiofilmsmicrobiologybiochemistryantimicrobial chemotherapy

Repurposing Clinically Approved Drugs for the Treatment of Bacillus Cereus, a Surrogate for Bacillus Anthracis. ACS Omega (2020)

antimicrobial agentsmedicineantimicrobial resistanceantimicrobial stewardshipinfection controlantibiotic adjuvantantimicrobial compoundsclinical microbiologyantimicrobial chemotherapyantimicrobial susceptibilityantibioticspathogenic bacteriahospital infectionsclinically approved drugsinfectious diseasesbacteriamicrobiologypharmaceutics

Role of a Small Molecule in the Modulation of Cell Death Signal Transduction Pathways. ACS Infectious Diseases (2018)

immunologysignaling pathwayscell deathcell signalingmolecular and cellular biologysmall moleculemolecular cell biologyapoptosismolecular biologymolecular pathwayscancer cellssignal transductioncell regulationcellular biochemistrycell biology

Bithionol Blocks Pathogenicity of Bacterial Toxins, Ricin and Zika Virus. Scientific Reports (2016)

William LeonardiLeeor ZilbermintzLuisa W. ChengJosue ZozayaSharon H. TranJeffrey H. ElliottKseniya PolukhinaRobert ManasherobAmy LiXiaoli ChiDima GharaibehTara KennyRouzbeh ZamaniVeronica SolovevaAndrew D. HaddowFarooq NasarSina BavariMichael C. BassikStanley N. CohenAnastasia LevitinMikhail Martchenko

public healthpathogensmicrobial pathogenesisinfection controlapplied microbiologyclinical microbiologyveterinary medicinepathogenic bacteriaglobal healthinfectious diseasesbacterial toxins

Cross-Inhibition of Pathogenic Agents and the Host Proteins They Exploit. Scientific Reports (2016)

immunologypathogensantiviral researchmicrobial pathogenesispathogenesispathogenic agentsinfection controlhost responseclinical microbiologyvirologyvirulence factorsinfectious diseasesmicrobiologyhost-microbe interactions

Recent Efforts in the Development of Therapies Against Zika Virus. Journal of Rare Disorders Diagnosis & Therapy (2016)

immunologyvaccinescommunicable diseasesvirus researchantiviral researchvector borne diseasezika virusmedical virologytropical medicineantiviral drugsvirologyvirus eradicationglobal healtharbovirusinfectious diseasesantiviral therapyneglected tropical diseasesinfectious diseases (medical specialty)

Identification of Agents Effective Against Multiple Toxins and Viruses by Host-Oriented Cell Targeting. Scientific Reports (2015)

Leeor ZilbermintzWilliam LeonardiSun-Young JeongMegan SjodtRyan McCombChi-Lee C. HoCary RettererDima GharaibehRouzbeh ZamaniVeronica SolovevaSina BavariAnastasia LevitinJoel WestKenneth A. BradleyRobert T. ClubbStanley N. CohenVivek GuptaMikhail Martchenko

public healthvirus researchpharmacologyviral persistencevirus-host interactionsinfection controlhost responseclinical microbiologymultiple toxinsvirologyhealth sciencesviral diagnostics

1
2
10 / page

Anastasia Levitin

Keck Graduate Institute

Affiliations

School of Medicine

NoneAnastasia Levitin is currently serving as a School Of Medicine faculty at Keck Graduate Institute.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Anastasia Levitin

Keck Graduate Institute

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Drosophila Melanogaster Y Chromosome Genes Affect Male Sensitivity to Microbial Infections. Insects (2021)

In Vivo Activity of Repurposed Amodiaquine as a Host-Targeting Therapy for the Treatment of Anthrax. ACS Infectious Diseases (2021)

Anthrax Toxin Component, Protective Antigen, Protects Insects From Bacterial Infections. PLoS Pathogens (2020)

public healthpathogensbacterial infectionsanthrax toxin componentprotective antigen

Identification of Bithionol, Dichlorophen, and Miconazole as Antibacterial Agents Against Acinetobacter Calcoaceticus. ACS Omega (2020)

Repurposing Clinically Approved Drugs for the Treatment of Bacillus Cereus, a Surrogate for Bacillus Anthracis. ACS Omega (2020)

Role of a Small Molecule in the Modulation of Cell Death Signal Transduction Pathways. ACS Infectious Diseases (2018)

Bithionol Blocks Pathogenicity of Bacterial Toxins, Ricin and Zika Virus. Scientific Reports (2016)

public healthpathogensmicrobial pathogenesisinfection controlapplied microbiologyclinical microbiologyveterinary medicinepathogenic bacteriaglobal healthinfectious diseasesbacterial toxins

Cross-Inhibition of Pathogenic Agents and the Host Proteins They Exploit. Scientific Reports (2016)

Recent Efforts in the Development of Therapies Against Zika Virus. Journal of Rare Disorders Diagnosis & Therapy (2016)

Identification of Agents Effective Against Multiple Toxins and Viruses by Host-Oriented Cell Targeting. Scientific Reports (2015)

public healthvirus researchpharmacologyviral persistencevirus-host interactionsinfection controlhost responseclinical microbiologymultiple toxinsvirologyhealth sciencesviral diagnostics

1
2
10 / page